Home › Kanser sa Tiyan › Texas › San Antonio

Pag-aaral pangklinika para sa Kanser sa Tiyan sa San Antonio, TX

19 pag-aaral para sa Kanser sa Tiyan ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng San Antonio (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo

Audie L Murphy VA Hospital, San Antonio

Edad 40 hanggang 75 · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT05334069

A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)

Nagre-recruitPhase 2/3

Texas Oncology - San Antonio, San Antonio

Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT07221149

Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors

Nagre-recruitPhase 1

NEXT Oncology - PARENT, San Antonio

Edad 18 pataas · Lahat ng kasarian · Na-update Set 29, 2026 · NCT07360314

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

Nagre-recruitPhase 1/2

NEXT Oncology San Antonio, San Antonio
START Texas, San Antonio

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT06128551

Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer

Nagre-recruitPhase 1/2

START South Texas Accelerated Research Therapeutics, San Antonio

Edad 18 pataas · Lahat ng kasarian · Na-update Set 18, 2026 · NCT05267626

A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors

Nagre-recruitPhase 1

NEXT Oncology, San Antonio

Edad 18 pataas · Lahat ng kasarian · Na-update Set 18, 2026 · NCT07705334

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

Nagre-recruitPhase 1

START - San Antonio, San Antonio

Edad 18 pataas · Lahat ng kasarian · Na-update Set 10, 2026 · NCT06293898

A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors

Nagre-recruitPhase 1/2

South Texas Accelerated Research Therapeutics (START), LLC, San Antonio

Edad 18 pataas · Lahat ng kasarian · Na-update Set 2, 2026 · NCT07070232

A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer

Nagre-recruitPhase 1

NEXT San Antonio, San Antonio

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 27, 2026 · NCT07227168

A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors

Nagre-recruitPhase 1/2

Research Site, San Antonio

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 19, 2026 · NCT07115043

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

Nagre-recruitPhase 1/2

UT Health Mays Cancer Center, San Antonio

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 11, 2026 · NCT05592626

A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors

Nagre-recruitPhase 1/2

Clinical Trial Site, San Antonio

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 6, 2026 · NCT07749586

IDOV-Immune for Advanced Solid Tumors

Nagre-recruitPhase 1

South Texas Accelerated Research Therapeutics, San Antonio

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 5, 2026 · NCT06910657

A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors

Nagre-recruitPhase 1

NEXT Virginia, LLC, San Antonio
South Texas Accelerated Research Therapeutics, LLC, San Antonio

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 22, 2026 · NCT05208762

A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors

Nagre-recruitPhase 1

South Texas Accelerated Research Therapeutics, LLC, San Antonio

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 22, 2026 · NCT06131840

A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors

Nagre-recruitPhase 1

START San Antonio, LLC., San Antonio

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 15, 2026 · NCT06657144

Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan

Nagre-recruitPhase 1

NEXT Oncology /ID# 243007, San Antonio
South Texas Accelerated Research Therapeutics (START) /ID# 276268, San Antonio

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 23, 2026 · NCT05005403

Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors

Nagre-recruitPhase 1/2

NEXT Oncology, San Antonio

Edad 18 pataas · Lahat ng kasarian · Na-update May 6, 2026 · NCT06239194

A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas

Nagre-recruitPhase 1

Dren Investigational Site, San Antonio

Edad 18 pataas · Lahat ng kasarian · Na-update Ene 7, 2026 · NCT06999187

Pag-aaral para sa Kanser sa Tiyan sa ibang lungsod

Iba pang pag-aaral sa San Antonio

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.